RAPT Therapeutics, Inc. (RAPT) Revenue History
Annual and quarterly revenue from 2017 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
RAPT Revenue Growth
RAPT Revenue Analysis (2017–2024)
As of May 6, 2026, RAPT Therapeutics, Inc. (RAPT) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, RAPT's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $5.0 million in 2020.
When compared to Healthcare sector peers including KYMR (-12.6% YoY), ARVN (-0.3% YoY), and RCUS (+67.4% YoY). Compare RAPT vs KYMR →
RAPT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| RAPTCurrent | $0 | - | - | - | |
 KYMR | $39M | -12.6% | +2.9% | -891.3% | |
 ARVN | $263M | -0.3% | +58.9% | -43.8% | |
 RCUS | $247M | +67.4% | +25.9% | -156.3% |
RAPT Historical Revenue Data (2017–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $0 | - | $-136,101,000 | - |
| 2023 | $0 | -100.0% | $0 | - | $-127,062,000 | - |
| 2022 | $1.5M | -60.0% | $1.5M | 100.0% | $-85,795,000 | -5618.5% |
| 2021 | $3.8M | -24.4% | $3.8M | 100.0% | $-69,209,000 | -1815.1% |
| 2020 | $5.0M | - | $5.0M | 100.0% | $-53,214,000 | -1055.4% |
| 2019 | $0 | - | $-1,330,000 | - | $-43,629,000 | - |
| 2018 | $0 | - | $-1,237,000 | - | $-36,947,000 | - |
| 2017 | $0 | - | $-1,384,000 | - | $-29,331,000 | - |
See RAPT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RAPT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RAPT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRAPT — Frequently Asked Questions
Quick answers to the most common questions about buying RAPT stock.
Is RAPT's revenue growth accelerating or slowing?
RAPT TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is RAPT's long-term revenue growth rate?
RAPT Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is RAPT's revenue distributed by segment?
RAPT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2024 are available for download. Segment mix reveals concentration and diversification trends.